Identification and validation of PSAT1 as a potential prognostic factor for predicting clinical outcomes in patients with colorectal carcinoma.

Qian, Cheng; Xia, Yongsheng; Ren, Yun; Yin, Yan; Deng, Anmei

Qian, Cheng; Xia, Yongsheng; Ren, Yun; Yin, Yan; Deng, Anmei.

Afiliación

Qian C; Department of General Surgery, Huzhou Maternity and Child Care Hospital, Huzhou, Zhejiang 313000, P.R. China.
Xia Y; Department of General Surgery, Huzhou Maternity and Child Care Hospital, Huzhou, Zhejiang 313000, P.R. China.
Ren Y; Department of General Surgery, Huzhou Maternity and Child Care Hospital, Huzhou, Zhejiang 313000, P.R. China.
Yin Y; Department of General Surgery, Huzhou Maternity and Child Care Hospital, Huzhou, Zhejiang 313000, P.R. China.
Deng A; Department of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China.

Oncol Lett ; 14(6): 8014-8020, 2017 Dec.

Article en En | MEDLINE | ID: mdl-29344244

Palabras clave

chemotherapy resistance; colorectal cancer; drug target; microarray; phosphoserine aminotransferase 1; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2017 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google